Paper Details

  1. Home
  2. Paper Details

(170)Tm-EDTMP: a potential cost-effective alternative to (89)SrCl(2) for bone pain palliation.

Author: BanerjeeSharmila, ChakrabortySudipta, DasTapas, PillaiMaroor R A, SarmaHaladhar D, TandonPankaj, VenkateshMeera

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Overview

A new radiopharmaceutical using 170Tm could potentially offer advantages over 89Sr for bone pain palliation, due to its longer half-life and lower beta particle energy.
Paper Details　
Original Abstract of the Article :
Metastron ((89)SrCl(2)) is a radiopharmaceutical currently used for bone pain palliation in several countries since the long half-life of (89)Sr (50.5 days) favors wider distribution than other radioisotopes approved for this application, which have shorter half-lives. Strontium-89 is not ideal for ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1016/j.nucmedbio.2009.02.002

データ提供：米国国立医学図書館（NLM）

(170)Tm-EDTMP: A Potential Cost-Effective Alternative for Bone Pain Palliation

Bone pain is a common and distressing symptom often associated with metastatic cancer. This study investigated the potential of (170)Tm-ethylenediaminetetramethylene phosphonic acid (EDTMP) as a cost-effective alternative to (89)SrCl(2) for bone pain palliation. The researchers aimed to explore the feasibility and effectiveness of (170)Tm-EDTMP as a new radiopharmaceutical for managing bone pain.

(170)Tm-EDTMP: A Promising Alternative for Bone Pain Relief

The study found that (170)Tm-EDTMP demonstrated promising results in animal models. The findings suggest that (170)Tm-EDTMP could be a viable and cost-effective alternative to (89)SrCl(2) for bone pain palliation. The study provides evidence for the potential of (170)Tm-EDTMP as a new radiopharmaceutical for managing bone pain and improving the quality of life for patients with metastatic cancer.

Improving Bone Pain Management: Exploring New Radiopharmaceuticals

This research highlights the importance of exploring new radiopharmaceuticals for bone pain palliation. (170)Tm-EDTMP demonstrates potential as a cost-effective alternative to existing treatments. This research underscores the ongoing efforts to develop innovative treatments for managing bone pain associated with metastatic cancer and improving the quality of life for patients.

Dr. Camel's Conclusion

This study investigates the potential of (170)Tm-EDTMP as a cost-effective alternative to (89)SrCl(2) for bone pain palliation. The findings suggest that (170)Tm-EDTMP could be a valuable addition to the armamentarium for managing bone pain in patients with metastatic cancer. It underscores the importance of continued research and development in exploring new radiopharmaceuticals for bone pain relief and improving the lives of those suffering from this debilitating condition.

Date :
  1. Date Completed 2009-09-10
  2. Date Revised 2016-11-25
Further Info :

Pubmed ID

19520297

DOI: Digital Object Identifier

10.1016/j.nucmedbio.2009.02.002

Related Literature

Article Analysis
・Effects of strontium-89 chloride
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.